By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Can-Fite BioPharma Ltd. 

Reinhold Cohn House
P.O.Box: 4060
Tel Aviv      Israel
Phone: 03-7109330 Fax: 03-5606405


Drug Discovery

Company News
Can-Fite BioPharma (CFBI) To Present At BIO CEO & Investor Conference In New York City On February 8, 2016 2/5/2016 6:58:37 AM
Can-Fite BioPharma (CFBI) CEO Dr. Pnina Fishman To Chair Scientific Session At The 2016 Purinergic Signaling And Cancer Immunotherapy Conference In Vancouver On January 26, 2016 1/25/2016 6:32:43 AM
U.S. Patent & Trademark Office Issues Notice Of Allowance For Can-Fite BioPharma (CFBI)'s Sexual Dysfunction Drug CF602 1/19/2016 6:07:40 AM
Can-Fite BioPharma (CFBI) To Present At Biotech Showcase In San Francisco On January 13, 2016 1/8/2016 8:47:15 AM
Can-Fite BioPharma (CFBI) Submits Phase III Protocol To IRB For CF101 In The Treatment Of Rheumatoid Arthritis 1/5/2016 7:00:14 AM
Can-Fite BioPharma (CFBI)'s CF101 Granted Patent In Japan For Intraocular Pressure A Key Cause Of Glaucoma 12/17/2015 6:39:32 AM
Can-Fite BioPharma (CFBI) Subsidiary, OphthaliX, Announces Completion Of Patient Enrollment In Phase II Glaucoma Study For CF101 12/7/2015 6:31:50 AM
Can-Fite BioPharma (CFBI) Reports Financial Results For Nine Months Ended September 30, 2015 11/30/2015 8:16:20 AM
Can-Fite BioPharma (CFBI) Announces Compelling Pre-Clinical Data On CF102 In The Treatment Of Non-Alcoholic Steatohepatitis (NASH) 11/23/2015 6:43:42 AM
Can-Fite BioPharma (CFBI) To Participate In BIO-Europe Partnering Conference On November 2-5, 2015 In Munich, Germany 10/26/2015 10:59:45 AM